Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
What's open and closed on Thanksgiving? Grocery and retail hours for 2024
Recommended
Photos: Sun lights up NC skies ð
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Disc Medicine, Inc. - Common Stock
(NQ:
IRON
)
64.96
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Disc Medicine, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Disc Medicine to Participate in Upcoming Investor Conferences
November 13, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
November 08, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
November 05, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday
November 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 04, 2024
Via
Benzinga
Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval
November 04, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)
November 01, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week
October 25, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer
October 23, 2024
Dr. Rahul Rajan Kaushik is an accomplished technical operations leader with over two decades of expertise in Chemistry, Manufacturing and Controls (CMC)
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week
October 11, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer
September 19, 2024
Dr. Steve Caffé is an accomplished industry executive with over 25 years of expertise in global product development and regulatory affairs
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine to Participate in Upcoming Investor Conferences
August 30, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
IRON Stock Earnings: Disc Medicine Beats EPS for Q2 2024
August 08, 2024
IRON stock results show that Disc Medicine beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Disc Medicine Reports Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
June 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 14, 2024
Via
Benzinga
Gold Gains 1%; US Consumer Sentiment Falls In June
June 14, 2024
Via
Benzinga
Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday
June 14, 2024
Via
Benzinga
Disc Medicine Announces Underwritten Offering of Common Stock
June 14, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
June 14, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine to Participate in the Jefferies Global Healthcare Conference
May 30, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
May 14, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
May 13, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
IRON Stock Earnings: Disc Medicine Misses EPS for Q1 2024
May 09, 2024
IRON stock results show that Disc Medicine missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
Disc Medicine Inc
Via
GlobeNewswire
Top 3 Health Care Stocks You'll Regret Missing This Month
April 02, 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Gold Gains 1%; CXApp Shares Spike Higher
April 01, 2024
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.3% on Monday. The Dow traded down 0.67% to 39,538.91 while the NASDAQ fell 0.06% to 16,369.44. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 01, 2024
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.